1357475
USP
拉坦前列素
United States Pharmacopeia (USP) Reference Standard
别名:
异丙基 (5Z,9α,11α,15R)-9,11,15-三羟基-17-苯基-18,19,20-三硝基苯-5-烯-1-酸酯, 异丙基 ( Z )-7-[(1 R ,2 R ,3 R ,5 S )-3,5-二羟基-2-[(3 R )-3-羟基-5-苯戊基] 环戊基] 庚烯-5-酸酯, 适利达
登录查看公司和协议定价
选择尺寸
关于此项目
经验公式(希尔记法):
C26H40O5
化学文摘社编号:
分子量:
432.59
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24
等级
pharmaceutical primary standard
API类
latanoprost
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
包装形式
neat
储存温度
−20°C
SMILES字符串
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
InChI
1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI key
GGXICVAJURFBLW-CEYXHVGTSA-N
基因信息
human ... PTGFR(5737)
正在寻找类似产品? 访问 产品对比指南
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Latanoprost USP reference standard for use in specified quality tests and assays.
Also used to prepare standard and system-suitability solutions for assay and impurity analysis according to the given below monographs of United States Pharmacopeia (USP):
Also used to prepare standard and system-suitability solutions for assay and impurity analysis according to the given below monographs of United States Pharmacopeia (USP):
- Latanoprost Compounded Topical Solution
- Latanoprost
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
免责声明
Sales restrictions may apply.
警示用语:
Warning
危险声明
危险分类
Repr. 2
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
此项目有
Latanoprost
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 47(2) (2022)
Latanoprost Compounded Topical Solution
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 46(3) (2021)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持